Anish Patel insider trades

Open-market stock purchases and sales by Anish Patel, CHIEF OPERATING OFFICER at Enliven Therapeutics, Inc, from SEC Form 4 filings since Feb 23, 2023.

Recent trades

DateStockTradeValue
Feb 12, 2026ELVN Enliven Therapeutics, IncBought (not open market)—
Feb 12, 2026ELVN Enliven Therapeutics, IncBought (not open market)—
Jan 9, 2026ELVN Enliven Therapeutics, IncSold$1.3M
Jan 9, 2026ELVN Enliven Therapeutics, IncSold$6.9K
Dec 8, 2025ELVN Enliven Therapeutics, IncSold$103K
Dec 8, 2025ELVN Enliven Therapeutics, IncSold$37.1K
Nov 7, 2025ELVN Enliven Therapeutics, IncSold$105K
Nov 7, 2025ELVN Enliven Therapeutics, IncSold$11K

Companies traded

  • ELVN Enliven Therapeutics, Inc: 45 sales, last Feb 12, 2026

Get free alerts when Anish Patel files a new trade →